This document is an equity summary statement from JP Morgan for Ghislaine Maxwell, covering the period from February 1, 2014, to February 28, 2014. It details the market value changes, unrealized gains/losses, and estimated annual income for EAFE Equity, including specific details for AstraZeneca PLC and GlaxoSmithKline PLC.
documents/vol00010-efta01519445-pdf.pdf
{"title":"JP Morgan Equity Summary for Ghislaine Maxwell","key_people":["Ghislaine Maxwell"],"document_date":"2014-02","document_type":"financial","document_subtype":"Equity Summary","key_organizations":["JP Morgan"],"reference_numbers":["JPM-SDNY-00046731","SDNY_GM_00315929","EFTA01519445"]}